HENDERSON, NV / ACCESSWIRE / March 6, 2019 / Cannabis research firm, ArcView, sees North American legal pot sales reaching $22 billion by 2021 and $57 billion worldwide by 2027. So, it's little surprise that investors have been backing stocks in the industry. Below are several newsmakers drawing investor interest.
One that we found with an interesting technology that has yet to find much market awareness is THC Therapeutics, Inc. (THCT). THCT has developed a soon to be patented, laboratory proven sanitizing Cannabis dryer, called the dHydronator® which can reduce moisture content of Cannabis to 10% in only 10-14 hours. The dHydronator® is dual function & also destroys harmful surface contaminants & pathogens.
Today we are highlighting: THC Therapeutics, Inc. (THCT), Bio-Path Holdings, Inc. (NASDAQ: BPTH), KushCo Holdings, Inc. (OTCQB: KSHB), Ascendis Pharma A/S (NASDAQ: ASND), Tilray, Inc. (TLRY), Canopy Growth Corporation (CGC), GW Pharmaceuticals plc (GWPH), and Terra Tech Corp. (TRTC).
THC Therapeutics, Inc. (THCT) (Market Cap: $90.916M; Share Price: $6.91) has developed a sanitizing herb dryer, The dHydronator®, their laboratory-proven product is specifically designed for drying and sanitizing freshly harvested Cannabis and herbs. THCT's product has been tested by two independent laboratories, testing covered over 6 strains and 9 independent tests to confirm the findings.
As we mentioned earlier, the US patent office has accepted ALL 20 claims for The dHydronator®; this is big! Start your research today.
Bio-Path Holdings, Inc. (BPTH) (Market Cap: $8.113M; Share Price: $4.615) recently announced an upcoming poster presentation at the 2019 American Association for Cancer Research (AACR) Annual Meeting, taking place from March 29 – April 3, 2019 in Atlanta, GA.
KushCo Holdings, Inc. (KSHB) (Market Cap: $521.910M; Share Price: $5.93) the parent company of several cannabis industry companies including Kush Supply Co., Kush Energy, The Hybrid Creative, and Koleto Innovations, announced recently that it had added Danny Moses, a private investor and entrepreneur best known for his role as a trader navigating the global financial crisis as chronicled in Michael Lewis's best-selling novel "The Big Short" and Adam McKay's Oscar-winning movie of the same name, and Tim Seymour, Chief Investment Officer of Seymour Asset Management, and best known as the co-host of CNBC's Fast Money, to the Company's Advisory Board.
Ascendis Pharma A/S (ASND) (Market Cap: $5.284B; Share Price: $125.40) recently announced positive top-line results from the phase 3 heiGHt Trial, a randomized, open-label, active-controlled trial that compared once-weekly TransCon Growth Hormone (hGH) to a daily growth hormone (Genotropin®) in children with pediatric growth hormone deficiency (GHD).
Tilray, Inc. (TLRY) (Market Cap: $7.276B; Share Price: $76.89) acquired Manitoba Harvest from Compass Diversified Holdings (CODI). The C$419 million purchase price consists of cash and Class 2 common stock shares of Tilray.
Canopy Growth Corporation (CGC) (Market Cap: $16.285B; Share Price: $47.88) announced last week that Martha Stewart has joined the company in an advisory role to develop products within the hemp-CBD space. The immediate focus will be on CBD products relating to pets.
GW Pharmaceuticals plc (GWPH) (Market Cap: $5.582B; Share Price: $172.57) reported impressive numbers highlighted by its strong launch for cannabinoid oil Epidiolex in seizure treatment. Epidiolex generated $4.7 million in sales over two months.
Terra Tech Corp. (TRTC) (Market Cap: $78.059M Share Price: $0.84) announced it has completed the renovation of its cultivation facility located on West Grand Avenue, Oakland, in California. One of the goals of the facility will be to research and develop various cultivation techniques to optimize efficiencies and crop yields. Planting of new crops is expected to commence later this week and all cannabis cultivated at the facility will be sold under the Company's premium IVXX™ brand to California's medical and adult-use markets.
Legal Disclaimer:
This article was written by Regal Consulting, LLC ("Regal Consulting"). Regal Consulting has agreed to a three-month term consulting agreement with THCT dated 2/14/18. The agreement calls for 50,000 restricted shares of THCT per month. All payments were made directly by THC Therapeutics, Inc. to Regal Consulting, LLC. to provide investor relations services, of which this article is a part of. Regal Consulting also paid one thousand dollars cash to microcapspeculators.com to distribute this article. Regal Consulting may have a position in the securities mentioned in this article at the time of publication, and may increase or decrease its position without notice. This article is based on public information and the opinions of Regal Consulting. THCT was given an opportunity to edit this article. This article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any results predicted herein. Regal Consulting is not registered with any financial or securities regulatory authority, and does not provide or claim to provide investment advice.
http://www.regalconsultingllc.com/full legal disclaimer/
Full Legal Disclaimer Click Here.
Contact Information:
Company Name: ACR Communication LLC.
Contact Person: Media Manager
Email: [email protected]
Phone: 1-702-720-6310
Country: United States
SOURCE: ACR Communication LLC.